Phase II study of pemetrexed as first-line treatment in elderly (≥75) non-squamous non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0901 von Kim, Young Hak, Hirabayashi, Masataka, Kosaka, Shinji, Nikaidoh, Junichi, Yamamoto, Yasumichi, Shimada, Masatoshi, Toyazaki, Toshiya, Nagai, Hiroki, Sakamori, Yuichi, Mishima, Michiaki

Volltext